Oscine Therapeutics IVS
CVR 38663062 · Entrepreneurial company (IVS) · Dissolved by declaration
Oscine Therapeutics IVS is a Entrepreneurial company (IVS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling indenfor bioteknologi. The company is no longer active (status: dissolved by declaration). 2 annual reports have been published. The latest annual report (31 Dec 2018) shows equity of DKK 5,585 and a net result of DKK -1,415.
Company details
- CVR number
- 38663062
- Status
- Dissolved by declaration
- Company type
- Entrepreneurial company (IVS)
- Founded
- Ceased
- Address
- c/o Copenhagen Bio Science Park, Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 7,000
- Auditor
- PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 77.5% |
| Current ratio | 444% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2018 | 2017 |
|---|---|---|
| Gross profit | DKK -1,415 | DKK 0 |
| Net profit | DKK -1,415 | DKK 0 |
| Equity | DKK 5,585 | DKK 7,000 |
| Total assets | DKK 7,208 | DKK 7,000 |
| Cash | DKK 7,000 | – |
| Short-term debt | DKK 1,623 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2018 – 31 Dec 2018 | 158 | ||
| 24 May 2017 – 31 Dec 2017 | 162 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Steven Alan Goldman | ||
| CEO | Christina Trojel-Hansen | ||
| Board | Steven Alan Goldman | ||
| Owner (67%) | Oscine Holding IVS | ||
| Owner (10%) | Trojel Venture IVS | ||
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | ||
| Founder | Oscine Holding IVS |
The CEOs' other companies
Steven Alan Goldman – 2 other companies
- Oscine Holding IVS Opløst
- Oscine Modeling IVS Opløst
Address history (1 moves)
| c/o Copenhagen Bio Science Park, Ole Maaløes Vej 3, 2200 København N | |
| c/o Nyborg & Rørdam Advokatfirma, Store Kongensgade 77, 3., 1264 København K |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Oscine Therapeutics IVS
Has Oscine Therapeutics IVS gone bankrupt?
No, Oscine Therapeutics IVS is not registered as bankrupt in the CVR register. Its status is: dissolved by declaration.
Who is the auditor of Oscine Therapeutics IVS?
Oscine Therapeutics IVS most recently used PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab.
When was Oscine Therapeutics IVS founded?
Oscine Therapeutics IVS was founded on 24 May 2017.
What is the equity of Oscine Therapeutics IVS?
Equity was DKK 5,585 according to the annual report for the period ending 31 December 2018.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.